{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:20:49Z","timestamp":1791300049496,"version":"4.1.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.smim.2009.05.012","type":"journal-article","created":{"date-parts":[[2009,7,12]],"date-time":"2009-07-12T08:28:51Z","timestamp":1247387331000},"page":"293-300","source":"Crossref","is-referenced-by-count":256,"title":["CD40 and autoimmunity: The dark side of a great activator"],"prefix":"10.1016","volume":"21","author":[{"given":"Anna L.","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Stunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail A.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2009.05.012_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-0-387-70630-6_11","article-title":"TRAF proteins in CD40 signaling","volume":"597","author":"Bishop","year":"2007","journal-title":"Adv Exp Biol Med"},{"issue":"1","key":"10.1016\/j.smim.2009.05.012_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/PL00000776","article-title":"The CD40\/CD154 receptor\/ligand dyad","volume":"58","author":"Schonbeck","year":"2001","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"10.1016\/j.smim.2009.05.012_bib3","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1172\/JCI200319301","article-title":"Abnormal GC reactions in SLE demonstrated by blockade of CD154-CD40 interactions","volume":"112","author":"Grammer","year":"2003","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.smim.2009.05.012_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/clim.2001.5172","article-title":"Aberrant expression of the costimulatory molecule CD40L on monocytes from patients with SLE","volume":"103","author":"Katsiari","year":"2002","journal-title":"Clin Immunol"},{"issue":"October","key":"10.1016\/j.smim.2009.05.012_bib5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nri1462","article-title":"The multifaceted roles of TRAFs in the regulation of B cell function","volume":"4","author":"Bishop","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.immuni.2008.06.015","article-title":"The TNFRs RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance","volume":"29","author":"Akiyama","year":"2008","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib7","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1073\/pnas.0810769106","article-title":"CD40\u2013CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells","volume":"106","author":"Iezzi","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8359","key":"10.1016\/j.smim.2009.05.012_bib8","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(83)90629-3","article-title":"Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity","volume":"2","author":"Bottazzo","year":"1983","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.gene.6364375","article-title":"A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression","volume":"8","author":"Jacobson","year":"2007","journal-title":"Genes Immun"},{"issue":"9","key":"10.1016\/j.smim.2009.05.012_bib10","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.2337\/db05-1673","article-title":"CD40\u2013CD40L interaction activates proinflammatory pathways in pancreatic islets","volume":"55","author":"Barbe-Tuana","year":"2006","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.smim.2009.05.012_bib11","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1073\/pnas.052247099","article-title":"Expression of CD40 identifies a unique pathogenic T cell population in T1D","volume":"99","author":"Wagner","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.smim.2009.05.012_bib12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.clim.2007.05.003","article-title":"A unique T cell subset described as CD4loCD40+ T cells in human T1D","volume":"124","author":"Waid","year":"2007","journal-title":"Clin Immunol"},{"issue":"2\u20133","key":"10.1016\/j.smim.2009.05.012_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2007.02.006","article-title":"The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future","volume":"28","author":"Jacobson","year":"2007","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.smim.2009.05.012_bib14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/clin.1997.4391","article-title":"Coexpression of CD40 and class II antigen HLA-DR in GD thyroid epithelial cells","volume":"84","author":"Faure","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"issue":"8","key":"10.1016\/j.smim.2009.05.012_bib15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/thy.1999.9.749","article-title":"CD40 expression in human thyroid tissue: evidence for involvement of multiple cell types in autoimmune and neoplastic diseases","volume":"9","author":"Smith","year":"1999","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.smim.2009.05.012_bib16","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1210\/en.2004-1617","article-title":"A GD-associated Kozak sequence SNP enhances the efficiency of CD40 gene translation: a case for translational pathophysiology","volume":"146","author":"Jacobson","year":"2005","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2567.1997.00421.x","article-title":"Suppression of murine thyroiditis via blockade of the CD40\u2013CD40L interaction","volume":"90","author":"Carayanniotis","year":"1997","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.smim.2009.05.012_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jaut.1998.0256","article-title":"CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous EAT","volume":"12","author":"Peterson","year":"1999","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaut.2008.04.001","article-title":"A new role for an old player: do B cells unleash the self-reactive CD8+ T cell storm necessary for the development of T1D?","volume":"31","author":"Marino","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.smim.2009.05.012_bib20","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.159.9.4620","article-title":"CD40L\u2013CD40 interactions are necessary for the initiation of insulitis and diabetes in NOD mice","volume":"159","author":"Balasa","year":"1997","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.smim.2009.05.012_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2337\/diabetes.55.01.06.db04-1154","article-title":"Costimulation blockade of both ICOS and CD40L induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse","volume":"55","author":"Nanji","year":"2006","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.smim.2009.05.012_bib22","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.161.8.3912","article-title":"B lymphocytes are critical APC for the initiation of T cell-mediated autoimmune diabetes in NOD mice","volume":"161","author":"Serreze","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.smim.2009.05.012_bib23","doi-asserted-by":"crossref","DOI":"10.2337\/db08-1504","article-title":"CD4+ CD25+ T cells control autoimmunity in the absence of B cells","author":"Marino","year":"2009","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.smim.2009.05.012_bib24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2337\/db07-0589","article-title":"MZB-cells of NOD mice expand with diabetes onset, invade the pancreatic LN, and present autoantigen to diabetogenic T-cells","volume":"57","author":"Marino","year":"2008","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.smim.2009.05.012_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/08916930701619169","article-title":"Autoantibodies in T1D","volume":"41","author":"Taplin","year":"2008","journal-title":"Autoimmunity"},{"issue":"5 Pt 1","key":"10.1016\/j.smim.2009.05.012_bib26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1600-6143.2005.01227.x","article-title":"Costimulation and autoimmune diabetes in BB rats","volume":"6","author":"Beaudette-Zlatanova","year":"2006","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.smim.2009.05.012_bib27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00125-004-1645-7","article-title":"A functional CD40 receptor is expressed in pancreatic beta cells","volume":"48","author":"Klein","year":"2005","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.smim.2009.05.012_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaut.2008.09.001","article-title":"CD40 on NOD CD4 T cells contributes to their activation and pathogenicity","volume":"31","author":"Baker","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.smim.2009.05.012_bib29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of MS","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu Rev Immunol"},{"issue":"March","key":"10.1016\/j.smim.2009.05.012_bib30","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1073\/pnas.93.6.2499","article-title":"CD40\u2013CD40L interactions in EAE and MS","volume":"93","author":"Gerritse","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.smim.2009.05.012_bib31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1073\/pnas.94.2.599","article-title":"Increased IL-12 production in pMS: induction by activated CD4+ T cells via CD40L","volume":"94","author":"Balashov","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-3083.2000.00688.x","article-title":"Elevated CD40L-expressing blood T-cell levels in MS are reversed by interferon-beta treatment","volume":"51","author":"Teleshova","year":"2000","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib33","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.4049\/jimmunol.161.3.1104","article-title":"Kinetics of expression of costimulatory molecules and their ligands in murine rEAE in vivo","volume":"161","author":"Issazadeh","year":"1998","journal-title":"J Immunol"},{"issue":"September (27)","key":"10.1016\/j.smim.2009.05.012_bib34","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.273.5283.1864","article-title":"Requirement for CD40L in costimulation induction, T cell activation, and EAE","volume":"273","author":"Grewal","year":"1996","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.smim.2009.05.012_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s001090050145","article-title":"CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation","volume":"75","author":"Samoilova","year":"1997","journal-title":"J Mol Med"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib36","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.4049\/jimmunol.166.3.1547","article-title":"Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ","volume":"166","author":"Howard","year":"2001","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.smim.2009.05.012_bib37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1172\/JCI5388","article-title":"Mechanisms of immunotherapeutic intervention by anti-CD40L antibody in an animal model of MS","volume":"103","author":"Howard","year":"1999","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.smim.2009.05.012_bib38","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/1521-4141(200102)31:2<527::AID-IMMU527>3.0.CO;2-D","article-title":"CD40-mediated activation of T cells accelerates, but is not required for, encephalitogenic potential of MBP-recognizing T cells in a model of pEAE","volume":"31","author":"Abromson-Leeman","year":"2001","journal-title":"Eur J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.smim.2009.05.012_bib39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0165-5728(02)00175-3","article-title":"Transient anti-CD154-mediated immunotherapy of ongoing rEAE induces long-term inhibition of disease relapses","volume":"129","author":"Howard","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.smim.2009.05.012_bib40","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0165-5728(99)00022-3","article-title":"Costimulatory signal blockade in murine rEAE","volume":"96","author":"Schaub","year":"1999","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.smim.2009.05.012_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0165-5728(99)00053-3","article-title":"Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis","volume":"97","author":"Tan","year":"1999","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.smim.2009.05.012_bib42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0165-5728(99)00152-6","article-title":"CD40 engagement stimulates IL-12p70 production by human microglial cells: basis for Th1 polarization in the CNS","volume":"102","author":"Becher","year":"2000","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib43","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4049\/jimmunol.176.3.1402","article-title":"CD40 expression by microglial cells is required for their completion of a two-step activation process during CNS autoimmune inflammation","volume":"176","author":"Ponomarev","year":"2006","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.smim.2009.05.012_bib44","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1084\/jem.193.8.967","article-title":"The clinical course of EAE and inflammation is controlled by the expression of CD40 within the CNS","volume":"193","author":"Becher","year":"2001","journal-title":"J Exp Med"},{"issue":"R2","key":"10.1016\/j.smim.2009.05.012_bib45","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1093\/hmg\/ddn246","article-title":"Autoimmune diseases: insights from genome-wide association studies","volume":"17","author":"Lettre","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.smim.2009.05.012_bib46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1399-0039.2006.00672.x","article-title":"Analysis of the C\/T(-1) SNP in the CD40 gene in MS","volume":"68","author":"Buck","year":"2006","journal-title":"Tissue Antigens"},{"issue":"12","key":"10.1016\/j.smim.2009.05.012_bib47","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/105072502321085234","article-title":"A C\/T SNP in the region of the CD40 gene is associated with GD","volume":"12","author":"Tomer","year":"2002","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.smim.2009.05.012_bib48","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/thy.2005.15.1119","article-title":"Association of CD40 gene polymorphism with susceptibility and phenotype of GD","volume":"15","author":"Kurylowicz","year":"2005","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.smim.2009.05.012_bib49","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1689","article-title":"Getting under the skin: the immunogenetics of psoriasis","volume":"5","author":"Bowcock","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.smim.2009.05.012_bib50","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"issue":"52","key":"10.1016\/j.smim.2009.05.012_bib51","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and iNOS-expressing DC in psoriasis and reduction with efalizumab","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.smim.2009.05.012_bib52","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/eji.1830261009","article-title":"CD40 is functionally expressed on human keratinocytes","volume":"26","author":"Denfeld","year":"1996","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.smim.2009.05.012_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000078582","article-title":"In situ expression of CD40 and CD40L in psoriasis","volume":"209","author":"Ohta","year":"2004","journal-title":"Dermatology"},{"issue":"12","key":"10.1016\/j.smim.2009.05.012_bib54","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.4049\/jimmunol.164.12.6621","article-title":"Up-regulation of CCL20 and CCR6 in psoriasis","volume":"164","author":"Homey","year":"2000","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib55","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/path.1581","article-title":"In situ demonstration of CD40- and CD154-positive cells in psoriatic lesions and keratinocyte production of chemokines by CD40 ligation in vitro","volume":"203","author":"Pasch","year":"2004","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.smim.2009.05.012_bib56","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/kel229","article-title":"Increased expression of CD40L on stimulated T-cells from patients with PsA","volume":"46","author":"Daoussis","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.smim.2009.05.012_bib57","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1084\/jem.192.5.681","article-title":"Blockade of T lymphocyte costimulation with CTLA4Ig reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, DC, and endothelial cells","volume":"192","author":"Abrams","year":"2000","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.smim.2009.05.012_bib58","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.clindermatol.2007.08.014","article-title":"Animal models of psoriasis","volume":"25","author":"Boehncke","year":"2007","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1016\/j.smim.2009.05.012_bib59","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1084\/jem.194.5.615","article-title":"Overexpression of CD40L in murine epidermis results in chronic skin inflammation and systemic autoimmunity","volume":"194","author":"Mehling","year":"2001","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib60","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3748\/wjg.14.338","article-title":"IBD: genetic and epidemiologic considerations","volume":"14","author":"Cho","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.smim.2009.05.012_bib61","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.183.2.693","article-title":"Blocking the CD40L\u2013CD40 interaction in vivo specifically prevents the priming of Th1 cells through the inhibition of IL-12 secretion","volume":"183","author":"Stuber","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.smim.2009.05.012_bib62","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.4049\/jimmunol.164.11.6005","article-title":"Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40\u2013CD154 interactions","volume":"164","author":"Liu","year":"2000","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.smim.2009.05.012_bib63","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/intimm\/9.8.1111","article-title":"Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice","volume":"9","author":"Clegg","year":"1997","journal-title":"Int Immunol"},{"issue":"10","key":"10.1016\/j.smim.2009.05.012_bib64","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/gut.52.10.1448","article-title":"Inducible CD40 expression mediates NFkappaB activation and cytokine secretion in human colonic fibroblasts","volume":"52","author":"Gelbmann","year":"2003","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.smim.2009.05.012_bib65","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.4049\/jimmunol.176.4.2617","article-title":"TNF-a blockade downregulates the CD40\/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in CD","volume":"176","author":"Danese","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.smim.2009.05.012_bib66","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.gastro.2005.05.013","article-title":"Characteristics of intestinal DC in IBD","volume":"129","author":"Hart","year":"2005","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.smim.2009.05.012_bib67","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.4049\/jimmunol.163.7.4049","article-title":"Hyperexpression of CD154 in IBD and its contribution to pathogenic cytokine production","volume":"163","author":"Liu","year":"1999","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.smim.2009.05.012_bib68","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1111\/j.1572-0241.1999.01538.x","article-title":"Expression of CD40 and CD40L in intestinal lesions of CD","volume":"94","author":"Battaglia","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.smim.2009.05.012_bib69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2036.2005.02526.x","article-title":"Safety and tolerability of antagonist anti-human CD40 mAb ch5D12 in patients with moderate to severe CD","volume":"22","author":"Kasran","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.smim.2009.05.012_bib70","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-065X.2008.00648.x","article-title":"The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in RA","volume":"223","author":"Noss","year":"2008","journal-title":"Immunol Rev"},{"issue":"11","key":"10.1016\/j.smim.2009.05.012_bib71","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1172\/JCI36389","article-title":"Evidence that cytokines play a role in RA","volume":"118","author":"Brennan","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.smim.2009.05.012_bib72","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jlb.58.2.209","article-title":"Ligation of CD40 on fibroblasts induces CD54 and CD106 upregulation, IL-6 production, and proliferation","volume":"58","author":"Yellin","year":"1995","journal-title":"J Leuk Biol"},{"key":"10.1016\/j.smim.2009.05.012_bib73","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1365-2249.1996.d01-858.x","article-title":"The functional CD40 antigen of fibroblasts may contribute to the proliferation of rheumatoid synovium","volume":"106","author":"Rissoan","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.smim.2009.05.012_bib74","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/art.20133","article-title":"Augmented production of chemokines by the interaction of type II collagen-reactive T cells with rheumatoid synovial fibroblasts","volume":"50","author":"Min","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.smim.2009.05.012_bib75","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/art.20106","article-title":"Effector function of type II collagen-stimulated T cells from RA patients: crosstalk between T cells and synovial fibroblasts","volume":"50","author":"Cho","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.smim.2009.05.012_bib76","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/art.20340","article-title":"Amplification of the synovial inflammatory response through activation of MAPKs and NF-kB using ligation of CD40 on CD14+ synovial cells from patients with RA","volume":"50","author":"Harigai","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.smim.2009.05.012_bib77","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/art.21873","article-title":"CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kB-dependent, CD40-mediated bone destruction in RA","volume":"54","author":"Lee","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib78","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1172\/JCI3162","article-title":"Nurse-like cells from bone marrow and synovium of patients with RA promote survival and enhance function of human B cells","volume":"102","author":"Shimaoka","year":"1998","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.smim.2009.05.012_bib79","first-page":"1035","article-title":"Ligation of CD40 induced TNF-alpha in RA: a novel mechanism of activation of synoviocytes","volume":"26","author":"Harigai","year":"1999","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.smim.2009.05.012_bib80","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/08916930109001958","article-title":"Expression of CD40 and CD40L among cell populations within rheumatoid synovial compartment","volume":"34","author":"Liu","year":"2001","journal-title":"Autoimmunity"},{"issue":"5","key":"10.1016\/j.smim.2009.05.012_bib81","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/rheumatology\/kep040","article-title":"A novel paradigm for DC as effectors of cartilage destruction","volume":"48","author":"Lakey","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.smim.2009.05.012_bib82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0","article-title":"Secretion of anti-CCP antibody by B lymphocytes in RA","volume":"44","author":"Reparon-Schuijt","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.smim.2009.05.012_bib83","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1172\/JCI119781","article-title":"Functional CD40L is expressed by T cells in RA","volume":"100","author":"MacDonald","year":"1997","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.smim.2009.05.012_bib84","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/1529-0131(199909)42:9<1917::AID-ANR18>3.0.CO;2-2","article-title":"Differential regulation of rheumatoid synovial cell interleukin-12 production by TNF-a and CD40 signals","volume":"42","author":"Kitagawa","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib85","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/ard.59.3.190","article-title":"Increased expression of CD154 on CD4+ T cells as a marker of disease activity in RA","volume":"59","author":"Berner","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.smim.2009.05.012_bib86","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.7689748","article-title":"Prevention of CIA with an antibody to gp39, the ligand for CD40","volume":"261","author":"Durie","year":"1993","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.smim.2009.05.012_bib87","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/1529-0131(200011)43:11<2571::AID-ANR26>3.0.CO;2-4","article-title":"The role of CD40L and TNF-alpha signaling in the transgenic K\/BxN mouse model of RA","volume":"43","author":"Kyburz","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.smim.2009.05.012_bib88","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/jaut.2000.0374","article-title":"Potent adjuvant effect by anti-CD40 in CIA. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma","volume":"14","author":"Tellander","year":"2000","journal-title":"J Autoimmun"},{"issue":"9","key":"10.1016\/j.smim.2009.05.012_bib89","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1002\/art.20425","article-title":"A genome-wide scan for jRA in affected sibpair families provides evidence of linkage","volume":"50","author":"Thompson","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.smim.2009.05.012_bib90","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ng.233","article-title":"Common variants at CD40 and other loci confer risk of RA","volume":"40","author":"Raychaudhuri","year":"2008","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.smim.2009.05.012_bib91","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/art.24245","article-title":"Genetic risk factors for RA differ in Caucasian and Korean populations","volume":"60","author":"Lee","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.smim.2009.05.012_bib92","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1186\/ar2288","article-title":"Association of the microsatellite in the 3\u2032-UTR of the CD154 gene with RA in females from a Spanish cohort: a case-control study","volume":"9","author":"Martin-Donaire","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib93","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1074-7613(01)00201-1","article-title":"Delineating the genetic basis of SLE","volume":"15","author":"Wakeland","year":"2001","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.smim.2009.05.012_bib94","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1172\/JCI118643","article-title":"Hyperexpression of CD40L by B and T cells in human lupus and its role in pathogenic autoantibody production","volume":"97","author":"Desai-Mehta","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.smim.2009.05.012_bib95","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1172\/JCI118855","article-title":"Increased expression of CD40 ligand on SLE lymphocytes","volume":"98","author":"Koshy","year":"1996","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.smim.2009.05.012_bib96","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4049\/jimmunol.168.1.9","article-title":"Cutting edge: ectopic expression of CD40L on B cells induces lupus-like autoimmune disease","volume":"168","author":"Higuchi","year":"2002","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.smim.2009.05.012_bib97","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/ard.2006.057885","article-title":"Efficacy of rituximab for refractory SLE involving the CNS","volume":"66","author":"Tokunaga","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.smim.2009.05.012_bib98","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/rheumatology\/ken071","article-title":"A dose-escalation study of rituximab for treatment of SLE and Evans\u2019 syndrome: immunological analysis of B cells, T cells and cytokines","volume":"47","author":"Tamimoto","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib99","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jaut.2006.02.002","article-title":"Elevated levels of sCD40L in serum of patients with systemic autoimmune diseases","volume":"26","author":"Goules","year":"2006","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.smim.2009.05.012_bib100","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1111\/j.1523-1755.2005.00663.x","article-title":"Activation of mesangial cells by platelets in SLE via a CD154-dependent induction of CD40","volume":"68","author":"Delmas","year":"2005","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.smim.2009.05.012_bib101","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/art.24257","article-title":"Increased expression of CD40 on bone marrow CD34+ HPCs in patients with SLE: contribution to Fas-mediated apoptosis","volume":"60","author":"Pyrovolaki","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib102","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.4049\/jimmunol.154.3.1470","article-title":"Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis","volume":"154","author":"Mohan","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.smim.2009.05.012_bib103","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.4049\/jimmunol.157.7.3159","article-title":"Anti-CD40L antibody treatment prevents the development of lupus-like nephritis in a subset of NZBxNZW mice","volume":"157","author":"Early","year":"1996","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.smim.2009.05.012_bib104","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/art.10929","article-title":"Effects of anti-CD154 treatment on B cells in murine SLE","volume":"48","author":"Wang","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.smim.2009.05.012_bib105","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.4049\/jimmunol.160.5.2158","article-title":"Anti-CD40L Ab treatment of SNF1 mice with established nephritis: preservation of kidney function","volume":"160","author":"Kalled","year":"1998","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.smim.2009.05.012_bib106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1191\/096120301668384751","article-title":"Long-term anti-CD154 dosing in nephritic mice is required to maintain survival and inhibit mediators of renal fibrosis","volume":"10","author":"Kalled","year":"2001","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.smim.2009.05.012_bib107","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.11230","article-title":"Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis","volume":"48","author":"Quezada","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.smim.2009.05.012_bib108","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.4049\/jimmunol.168.4.2046","article-title":"Mechanism of action of combined short-term CTLA4Ig and anti-CD40L in murine SLE","volume":"168","author":"Wang","year":"2002","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.smim.2009.05.012_bib109","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1086\/503686","article-title":"Fine-mapping chromosome 20 in 230 SLE sib-pair and multiplex families: evidence for genetic epistasis with chromosome 16q12","volume":"78","author":"Gaffney","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.smim.2009.05.012_bib110","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood-2008-02-138925","article-title":"A novel polymorphism of the human CD40 receptor with enhanced function","volume":"112","author":"Peters","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.smim.2009.05.012_bib111","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/art.22672","article-title":"A multiethnic, multicenter cohort of patients with SLE as a model for the study of ethnic disparities in SLE","volume":"57","author":"Fernandez","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.smim.2009.05.012_bib112","series-title":"Therapeutic targets of the TNF superfamily","first-page":"8","article-title":"Therapeutic interventions targeting CD40L and CD40: the opportunities and challenges","author":"Law","year":"2009"},{"issue":"1","key":"10.1016\/j.smim.2009.05.012_bib113","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.jid.5700059","article-title":"Inhibition of pemphigus vulgaris by targeting of the CD40\u2013CD154 co-stimulatory pathway: a step toward antigen-specific therapy?","volume":"126","author":"Liu","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.smim.2009.05.012_bib114","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/ard.2007.073387","article-title":"Blockade of CD40\u2013CD40L interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse","volume":"67","author":"Komura","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.smim.2009.05.012_bib115","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/gast.2000.16485","article-title":"Chronic murine colitis is dependent on the CD154\/CD40 pathway and can be attenuated by anti-CD154 administration","volume":"119","author":"De Jong","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.smim.2009.05.012_bib116","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/08916930400002386","article-title":"The role of CD40\u2013CD154 interaction in autoimmunity and the benefit of disrupting this pathway","volume":"37","author":"Toubi","year":"2004","journal-title":"Autoimmunity"},{"issue":"8","key":"10.1016\/j.smim.2009.05.012_bib117","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/01.TP.0000135457.69220.5B","article-title":"Thrombophilia associated with anti-Cd154 mAb treatment and its prophylaxis in nonhuman primates","volume":"78","author":"Roth","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.smim.2009.05.012_bib118","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/01.RES.0000074030.98009.FF","article-title":"CD40\u2013CD40L and platelet function: beyond hemostasis","volume":"92","author":"Freedman","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.smim.2009.05.012_bib119","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nm0302-247","article-title":"CD40L stabilizes arterial thrombi by a b3 integrin-dependent mechanism","volume":"8","author":"Andre","year":"2002","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.smim.2009.05.012_bib120","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/art.10273","article-title":"The effect of anti-CD40L Ab on B cells in human SLE","volume":"46","author":"Huang","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.smim.2009.05.012_bib121","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/art.10856","article-title":"A short course of BG9588 improves serologic activity and decreases hematuria in patients with proliferative lupus GN","volume":"48","author":"Boumpas","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.smim.2009.05.012_bib122","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2141.2008.07039.x","article-title":"The effect of anti-CD40L in ITP","volume":"141","author":"Patel","year":"2008","journal-title":"Brit J Hematol"},{"issue":"12","key":"10.1016\/j.smim.2009.05.012_bib123","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/art.10681","article-title":"Treatment of SLE by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial","volume":"46","author":"Kalunian","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.smim.2009.05.012_bib124","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/intimm\/dxh162","article-title":"The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge","volume":"16","author":"Ferrant","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.smim.2009.05.012_bib125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.173.2.993","article-title":"FcR interactions do not play a major role in inhibition of EAE by anti-CD154 mAbs","volume":"173","author":"Nagelkerken","year":"2004","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.smim.2009.05.012_bib126","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1399-3011.2005.00256.x","article-title":"Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade","volume":"65","author":"Allen","year":"2005","journal-title":"J Peptide Res"},{"key":"10.1016\/j.smim.2009.05.012_bib127","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10165-005-0442-6","article-title":"Identification of three novel peptides that inhibit CD40\u2013CD154 interaction","volume":"15","author":"Kitagawa","year":"2005","journal-title":"Mod Rheumatol"},{"issue":"13","key":"10.1016\/j.smim.2009.05.012_bib128","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1158\/0008-5472.CAN-04-4125","article-title":"Human anti-CD40 antagonist Ab triggers significant antitumor activity against human MM","volume":"65","author":"Tai","year":"2005","journal-title":"Cancer Res"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104453230900058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104453230900058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T23:47:28Z","timestamp":1685058448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104453230900058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":128,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S104453230900058X"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2009.05.012","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}